ReviewBritish journal of pharmacology2015

Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

M Borsotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.